## Review

### Soundness: **52/100**
The paper addresses a relevant problem and reports consistent improvements across two datasets, but several methodological details limit confidence in the results:

- The cohort construction, sepsis-labeling procedure, prediction-window sampling, handling of recurrent admissions, and censoring are insufficiently specified.
- Sepsis labels based on Sepsis-3 depend on time-varying events such as cultures, antibiotics, and organ dysfunction. The paper does not explain how label leakage is prevented, especially when predicting six hours before onset.
- Measurements are grouped into hourly windows, yet the model uses the time since the “most recent previous measurement of each variable.” The precise construction of these intervals and how missing values are handled is unclear.
- The comparison may not be fully fair: baselines use hyperparameters from their original papers, whereas TimeWarn is tuned by a 72-configuration search on each dataset.
- Statistical significance testing, confidence intervals, and patient-level bootstrap estimates are absent.
- Only one ablation is reported, and there is no analysis of sensitivity to window size, observation density, decay parameterization, or label definition.
- Attention weights are treated as explanations without faithfulness or stability analyses. High attention to clinically relevant variables does not by itself establish interpretability.

The results are plausible, but the paper currently does not provide enough information to reproduce or verify them.

### Novelty: **62/100**
The central idea—combining RETAIN-style two-level attention with learned time decay—is reasonable and potentially useful. However, the novelty appears incremental because:

- RETAIN already provides the attention architecture.
- GRU-D and related models already incorporate elapsed-time information through decay.
- The proposed mechanism mainly multiplies attention weights by a learned exponential decay, without a clearly new temporal representation or theoretical contribution.

The combination may be practically valuable, but the paper should more clearly distinguish its method from existing time-aware attention, decay-based RNN, and irregular-time transformer approaches.

### Significance: **70/100**
Early sepsis prediction is clinically important, and evaluation on MIMIC-IV and eICU could make the work impactful. The reported gains over GRU-D and RETAIN are potentially meaningful, and the six-hour and twelve-hour lead-time analyses are relevant.

However, the clinical significance is difficult to assess because:

- There is no calibration, decision-curve, sensitivity-at-fixed-specificity, or alarm-burden analysis.
- No prospective or workflow evaluation is provided.
- The datasets are ICU-focused, limiting generalizability to wards and other healthcare systems.
- The absolute improvement over GRU-D is modest and may not translate into better clinical decisions.

### Clarity: **78/100**
The paper is generally well organized and readable. The motivation, architecture, and main findings are easy to follow. The table is clear and the contribution statements are concise.

Important details are nevertheless missing or ambiguous, including:

- Exact input representation and imputation procedure.
- The sequence length and treatment of variable measurement timestamps.
- Whether attention is normalized before or after decay.
- The precise sepsis onset definition and exclusion criteria.
- Train/validation/test splitting at the admission versus patient level.
- Whether results are averaged over five seeds for all neural models and how variability is computed.
- Baseline implementation and tuning procedures.

These omissions reduce reproducibility and make the reported comparison harder to interpret.

## Scores

| Criterion | Score |
|---|---:|
| Soundness | 52 |
| Novelty | 62 |
| Significance | 70 |
| Clarity | 78 |
| **Final average** | **65.5** |

## Final recommendation: **Reject**

The topic is important and the proposed model is potentially useful, but the current submission lacks sufficient methodological detail and experimental rigor to support its claims. A substantially revised version should address leakage prevention, cohort and label construction, fair baseline tuning, reproducibility, calibration and clinical utility, and stronger validation of the interpretability claims.